EGFR and lung adenocarcinoma: Analysis of the DNA sequencing data obtained from the patients’ tumors revealed a mutational landscape with the typical distribution of frequently mutated genes in early-stage lung adenocarcinomas (LUAD): 34% EGFR, 25% KRAS, 22% TP53 and 7% STK11 (Fig. 2a).